Breast Cancer Mortality Falls Globally Despite Rising Cases: 2023 Study & 2050 Projections

The global landscape of breast cancer is marked by a complex duality: while mortality rates have declined over the past three decades, the number of cases continues to rise. This trend, coupled with an aging global population, paints a concerning picture for the future, with projections indicating a potential increase in both diagnoses and deaths by 2050. A comprehensive study published on March 2, 2026, in The Lancet Oncology, based on the Global Burden of Diseases (GBD) study, provides a detailed assessment of these epidemiological shifts and the associated risk factors.

The GBD 2023 study, a systematic analysis of data from 204 countries and territories between 1990 and 2023, reveals a significant reduction in breast cancer mortality rates worldwide. This positive development is largely attributed to advancements in early detection through increased screening programs and the availability of innovative treatments, particularly in high-income nations. However, this progress is tempered by the simultaneous increase in the incidence of the disease, driven in part by demographic changes and lifestyle factors. The study underscores that breast cancer remains a leading cause of morbidity and mortality among women globally, demanding continued attention and investment in prevention, diagnosis and treatment strategies.

Declining Mortality, Rising Incidence: A Global Overview

The research team meticulously estimated breast cancer incidence, mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) by age and sex. Mortality estimates were generated using GBD Cause of Death Ensemble models, incorporating data from population-based cancer registration systems, vital registration systems, and verbal autopsies. Prevalence was calculated by combining incidence and modeled survival estimates. The study highlights a notable decrease in mortality rates, but emphasizes that this decline may not be sustainable as populations age and risk factors become more prevalent. Specifically, the study forecasts approximately 3.5 million diagnoses and 1.4 million deaths annually worldwide by 2050.

The findings are particularly relevant in the context of global health disparities. The study points to a difference in both incidence and mortality rates based on a country’s economic status. Incidence rates are generally higher in high-income countries, while mortality rates are lower, suggesting that access to early detection and effective treatment plays a crucial role in improving outcomes. This disparity underscores the need for equitable access to healthcare resources and preventative measures globally. Marina Pollán, Director General of the Instituto de Salud Carlos III (ISCIII) in Spain, emphasized the importance of the study, stating that it “highlights the burden of disease of this tumor which constitutes a public health problem worldwide, the different life expectancy of women with this disease in countries with higher and lower income, and also shows the role of some of the modifiable risk factors.”

Spain’s Progress and the Role of Screening

The study’s findings also offer insights into regional trends. In Spain, mortality rates have decreased by nearly 42% between 1990 and 2023, a reduction attributed to the expansion of breast cancer screening programs and the increased availability of innovative treatments. However, data comparisons between the GBD study and the Sistema de Información Español de Cáncer (SIEC) reveal some discrepancies. The SIEC estimated approximately 35,540 cases in Spain for 2023, while the GBD study suggests a figure closer to 29,400, with an uncertainty range of 24,600 to 34,400. Similarly, the SIEC reported 6,405 deaths in Spain in 2023, lower than the 7,890 estimated by the GBD study. These differences highlight the challenges of accurately tracking cancer incidence and mortality across different data sources and methodologies.

Alejandro Pérez Fidalgo, a physician specializing in oncology and hematology at the Instituto de Investigación Sanitaria Clínico Valencia (Incliva), and a member of the Sociedad Española de Oncología Médica (SEOM), lauded Spain’s progress, noting that the decline in mortality is even greater than the average reduction observed in wealthy nations. He attributed this success to the country’s robust healthcare system and its strategic approach to combating breast cancer. “The effort made in European countries, including Spain, has a positive impact on the health of the population,” he stated, emphasizing the importance of sustained investment in cancer prevention and treatment.

The Impact of Aging Populations and Modifiable Risk Factors

The projected increase in breast cancer cases and deaths by 2050 is largely linked to the anticipated growth of the global aging population. As people live longer, the risk of developing cancer naturally increases. However, the study also identifies several modifiable risk factors that contribute to the burden of the disease. These include dietary habits, tobacco use, and high blood glucose levels. Other factors, such as obesity, excessive alcohol consumption, and a sedentary lifestyle, also play a role, albeit to a lesser extent. Addressing these risk factors through public health initiatives and individual lifestyle changes is crucial for mitigating the future impact of breast cancer.

The GBD study utilized a comparative risk assessment framework to examine the contribution of these seven risk factors to the overall burden of breast cancer. This analysis provides valuable insights into the areas where targeted interventions could have the greatest impact. For example, promoting healthy diets, encouraging smoking cessation, and managing blood glucose levels could significantly reduce the incidence of the disease. Increasing awareness of these risk factors and empowering individuals to make informed choices about their health are essential components of a comprehensive cancer prevention strategy.

Key Takeaways

• Breast cancer remains a significant global health challenge, with rising incidence rates despite declining mortality.
• Aging populations are a major driver of projected increases in both diagnoses and deaths by 2050.
• Early detection through screening programs and access to innovative treatments are crucial for improving outcomes.
• Modifiable risk factors, such as diet, tobacco use, and blood glucose levels, play a significant role in the development of the disease.
• Addressing health disparities and ensuring equitable access to healthcare are essential for reducing the global burden of breast cancer.

The findings from this extensive study underscore the urgent need for continued research, investment, and collaboration in the fight against breast cancer. While significant progress has been made in reducing mortality rates, the projected increase in cases due to demographic shifts and lifestyle factors demands a proactive and comprehensive approach. Further research is needed to identify new and more effective prevention strategies, diagnostic tools, and treatment options. The global health community must work together to ensure that all women have access to the care they need to prevent, detect, and treat this devastating disease. The next major update from the GBD study is anticipated in 2028, providing further insights into the evolving landscape of breast cancer and informing future public health interventions.

What are your thoughts on the future of breast cancer research and prevention? Share your comments below, and please share this article with your network to raise awareness about this critical health issue.